In particular, 3 CpGs in WDR8 were detected across overall, estrogen receptor/progesterone receptor–positive (ER/PR +), and human epidermal growth factor receptor-2–negative (HER2/neu–) subtypes, with a positive association with BC risk (Table 4, Additional file 1: Figure S2). This evidence concerns the gene ERBB2 and breast cancer.